ENvue Medical (FEED) Cash & Equivalents (2014 - 2026)

ENvue Medical (FEED) has reported Cash & Equivalents for 13 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 73.1% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 73.1% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, up 461.7% from the prior year.
• Cash & Equivalents was $1.1 million for Q2 2026 at ENvue Medical, down from $2.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $7.0 million in Q3 2025 and troughed at $253000.0 in Q2 2023.
• A 5-year average of $2.8 million and a median of $2.5 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 93.59% in 2023 and surged 757.71% in 2024, its largest moves.
• Over 5 years, Cash & Equivalents stood at $2.7 million in 2022, then increased by 21.01% to $3.3 million in 2023, then plunged by 77.09% to $752000.0 in 2024, then soared by 461.7% to $4.2 million in 2025, then tumbled by 74.34% to $1.1 million in 2026.
• The last three Cash & Equivalents figures came in at $1.1 million (Q2 2026), $2.2 million (Q1 2026), and $4.2 million (Q4 2025), per Business Quant data.